Synergy Pharmaceuticals Announces Partial Exercise of Over-Allotment Option by …
NEW YORK, Jun 5, 2012 (GlobeNewswire via COMTEX) — Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) , a developer of new drugs to treat gastrointestinal disorders and diseases, announced the partial exercise of the over-allotment option granted to the …
See all stories on this topic »